On Tuesday, February 3, Congress passed five of the remaining appropriations bills, including the Fiscal Year (FY) 2026 Labor, Health and Human Services, Education and Related Agencies (Labor-HHS) appropriations bill, which included $116.5 billion for HHS and rejected the administration's proposed cuts to health care programs.

The package included several health care provisions, including a two-year extension of Medicare telehealth flexibilities, and transparency measures and rebate passthroughs for pharmacy benefit managers (PBMs). It also included the Multi-Cancer Early Detection Screening Coverage Act (MCED), which would allow for Medicare coverage of FDA-approved early detection screening tests, and which HOPA supports.

Advocacy

End Cancer Drug Shortages Coalition: A Consensus Statement on Drug Shortages

HOPA has spearheaded a multi-year initiative with 16 other organizations to establish the consensus for combating cancer drug shortages. The statement outlines the major factors contributing to this crisis, and recommends policy solutions.

HOPA logo
Advocacy

HOPA Issues Updated Drug Shortages Brief

Shortages of drugs that are essential for the treatment and care of individuals with cancer result in compromises to patient care and, ultimately, outcomes.

An oncology pharmacist helping a patient
Advocacy

Oncology Pharmacist Survey: Understanding Task Value and Professional Satisfaction

Recent publications have explored workload and productivity to improve oncology pharmacy practice. HOPA aimed to build upon that research by assessing task valuation.